Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07569757 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07569757
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.